Obinutuzumab, a Potent Anti–B-Cell Agent, for Rituximab-Unresponsive IgM Anti-Mag Neuropathy
Neurology: Neuroimmunology and NeuroInflammation - United States
doi 10.1212/nxi.0000000000000460
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 5, 2018
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)